Researchers uncovered hundreds of genes linked to OCD, providing clues about how it changes the brain − new research
In The Conversation, Dr. Carol Mathews explains her new study in Nature Genetics shedding light on the genetics of OCD.
Posted in
The Conversation
A neuroscientist explains the science of pain
In The Conversation's Curious Kids series, Dr. Yenisel Cruz-Almeida explains pain, how it travels, and why it's needed as a warning signal.
Brain inflammation may be the reason behind muscle fatigue after infection and injury
In The Conversation, Dr. Diego Rincon-Limas discusses the role brain inflammation may play in muscle fatigue in cases of long COVID, Alzheimer's, or E. coli infections
Are older adults more vulnerable to scams?
In The Conversation, Drs. Natalie Ebner and Didem Pehlivanoglu discuss the factors that shape vulnerability to scams in older adults.
Brain cancer in children is notoriously hard to treat – a new mRNA cancer vaccine triggers an attack from within
In The Conversation Drs. John Ligon and Christina von Roemeling discuss new paper they co-authored in the journal Cell.
Newly discovered genetic variant that causes Parkinson’s disease clarifies why the condition develops and how to halt it
In The Conversation, Dr. Matthew Farrer discusses his team's new paper published in The Lancet Neurology.
A century after the EEG was discovered, it remains a crucial tool for understanding the brain
In The Conversation, Dr. Giridhar Kalamangalam tells the story of the game-changing medical test that measures brain electrical activity.
Bacteria in your gut can improve your mood − new research in mice tries to zero in on the crucial strains
In The Conversation, Dr. Andrea Merchak explains her team’s research into probiotics and whether microscopic organisms in the gut may play a role in regulating stress.
Aerobic and strength training exercise combined can be an elixir for better brain health in your 80s and 90s, new study finds
In The Conversation, Drs. Brian Ho and Ronald Cohen explain the key findings in a recent study.
Alzheimer’s disease is partly genetic − studying the genes that delay decline in some may lead to treatments for all
In The Conversation, UF neuroscientist Dr. Steven DeKosky explains new discoveries with treatment implications.
